ID MYH4_HUMAN Reviewed; 1939 AA. AC Q9Y623; DT 27-APR-2001, integrated into UniProtKB/Swiss-Prot. DT 03-MAR-2009, sequence version 2. DT 27-MAR-2024, entry version 191. DE RecName: Full=Myosin-4; DE AltName: Full=Myosin heavy chain 2b; DE Short=MyHC-2b; DE AltName: Full=Myosin heavy chain 4; DE AltName: Full=Myosin heavy chain IIb; DE Short=MyHC-IIb; DE AltName: Full=Myosin heavy chain, skeletal muscle, fetal; GN Name=MYH4; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS MET-1106; LYS-1209; GLY-1802 AND RP GLU-1911. RC TISSUE=Skeletal muscle; RX PubMed=10388558; DOI=10.1006/jmbi.1999.2865; RA Weiss A., Schiaffino S., Leinwand L.A.; RT "Comparative sequence analysis of the complete human sarcomeric myosin RT heavy chain family: implications for functional diversity."; RL J. Mol. Biol. 290:61-75(1999). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16625196; DOI=10.1038/nature04689; RA Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., RA Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A., RA Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J., RA Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J., RA DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S., RA Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E., RA Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K., RA LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J., RA Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A., RA Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., RA Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D., RA Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A., RA Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.; RT "DNA sequence of human chromosome 17 and analysis of rearrangement in the RT human lineage."; RL Nature 440:1045-1049(2006). CC -!- FUNCTION: Muscle contraction. CC -!- SUBUNIT: Muscle myosin is a hexameric protein that consists of 2 heavy CC chain subunits (MHC), 2 alkali light chain subunits (MLC) and 2 CC regulatory light chain subunits (MLC-2). CC -!- SUBCELLULAR LOCATION: Cytoplasm, myofibril. Note=Thick filaments of the CC myofibrils. CC -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles CC of a 28-residue repeat pattern composed of 4 heptapeptides, CC characteristic for alpha-helical coiled coils. CC -!- DOMAIN: Limited proteolysis of myosin heavy chain produces 1 light CC meromyosin (LMM) and 1 heavy meromyosin (HMM). HMM can be further CC cleaved into 2 globular subfragments (S1) and 1 rod-shaped subfragment CC (S2). {ECO:0000305}. CC -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase CC superfamily. Myosin family. {ECO:0000305}. CC -!- CAUTION: Represents a conventional myosin. This protein should not be CC confused with the unconventional myosin-4 (MYO4). {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF111783; AAD29949.1; -; mRNA. DR EMBL; AC005323; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR CCDS; CCDS11154.1; -. DR RefSeq; NP_060003.2; NM_017533.2. DR RefSeq; XP_016880165.1; XM_017024676.1. DR AlphaFoldDB; Q9Y623; -. DR SMR; Q9Y623; -. DR BioGRID; 110707; 85. DR IntAct; Q9Y623; 21. DR MINT; Q9Y623; -. DR STRING; 9606.ENSP00000255381; -. DR iPTMnet; Q9Y623; -. DR PhosphoSitePlus; Q9Y623; -. DR BioMuta; MYH4; -. DR DMDM; 224471840; -. DR EPD; Q9Y623; -. DR jPOST; Q9Y623; -. DR MassIVE; Q9Y623; -. DR MaxQB; Q9Y623; -. DR PaxDb; 9606-ENSP00000255381; -. DR PeptideAtlas; Q9Y623; -. DR ProteomicsDB; 86589; -. DR Pumba; Q9Y623; -. DR Antibodypedia; 62478; 165 antibodies from 23 providers. DR DNASU; 4622; -. DR Ensembl; ENST00000255381.2; ENSP00000255381.2; ENSG00000264424.1. DR GeneID; 4622; -. DR KEGG; hsa:4622; -. DR MANE-Select; ENST00000255381.2; ENSP00000255381.2; NM_017533.2; NP_060003.2. DR UCSC; uc002gmn.4; human. DR AGR; HGNC:7574; -. DR CTD; 4622; -. DR DisGeNET; 4622; -. DR GeneCards; MYH4; -. DR HGNC; HGNC:7574; MYH4. DR HPA; ENSG00000264424; Tissue enriched (skeletal). DR MIM; 160742; gene. DR neXtProt; NX_Q9Y623; -. DR OpenTargets; ENSG00000264424; -. DR PharmGKB; PA31371; -. DR VEuPathDB; HostDB:ENSG00000264424; -. DR eggNOG; KOG0161; Eukaryota. DR GeneTree; ENSGT00940000163211; -. DR HOGENOM; CLU_000192_8_0_1; -. DR InParanoid; Q9Y623; -. DR OMA; PGEVNQP; -. DR OrthoDB; 2877572at2759; -. DR PhylomeDB; Q9Y623; -. DR TreeFam; TF314375; -. DR PathwayCommons; Q9Y623; -. DR SignaLink; Q9Y623; -. DR BioGRID-ORCS; 4622; 23 hits in 1147 CRISPR screens. DR GeneWiki; MYH4; -. DR GenomeRNAi; 4622; -. DR Pharos; Q9Y623; Tbio. DR PRO; PR:Q9Y623; -. DR Proteomes; UP000005640; Chromosome 17. DR RNAct; Q9Y623; Protein. DR Bgee; ENSG00000264424; Expressed in skeletal muscle tissue of rectus abdominis and 22 other cell types or tissues. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005859; C:muscle myosin complex; NAS:BHF-UCL. DR GO; GO:0030016; C:myofibril; IDA:BHF-UCL. DR GO; GO:0032982; C:myosin filament; IBA:GO_Central. DR GO; GO:0016460; C:myosin II complex; IBA:GO_Central. DR GO; GO:0030017; C:sarcomere; NAS:BHF-UCL. DR GO; GO:0051015; F:actin filament binding; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016887; F:ATP hydrolysis activity; NAS:BHF-UCL. DR GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW. DR GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI. DR GO; GO:0000146; F:microfilament motor activity; IBA:GO_Central. DR GO; GO:0030048; P:actin filament-based movement; NAS:UniProtKB. DR GO; GO:0046034; P:ATP metabolic process; NAS:BHF-UCL. DR GO; GO:0006936; P:muscle contraction; IDA:BHF-UCL. DR GO; GO:0030049; P:muscle filament sliding; NAS:BHF-UCL. DR CDD; cd14915; MYSc_Myh4; 1. DR Gene3D; 1.10.10.820; -; 1. DR Gene3D; 1.20.5.340; -; 5. DR Gene3D; 1.20.5.370; -; 4. DR Gene3D; 1.20.5.4820; -; 1. DR Gene3D; 1.20.58.530; -; 1. DR Gene3D; 6.10.250.2420; -; 1. DR Gene3D; 3.40.850.10; Kinesin motor domain; 1. DR Gene3D; 2.30.30.360; Myosin S1 fragment, N-terminal; 1. DR Gene3D; 1.20.120.720; Myosin VI head, motor domain, U50 subdomain; 1. DR InterPro; IPR000048; IQ_motif_EF-hand-BS. DR InterPro; IPR036961; Kinesin_motor_dom_sf. DR InterPro; IPR001609; Myosin_head_motor_dom. DR InterPro; IPR004009; Myosin_N. DR InterPro; IPR008989; Myosin_S1_N. DR InterPro; IPR002928; Myosin_tail. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR014751; XRCC4-like_C. DR PANTHER; PTHR45615; MYOSIN HEAVY CHAIN, NON-MUSCLE; 1. DR PANTHER; PTHR45615:SF78; MYOSIN-4; 1. DR Pfam; PF00063; Myosin_head; 1. DR Pfam; PF02736; Myosin_N; 1. DR Pfam; PF01576; Myosin_tail_1; 1. DR PRINTS; PR00193; MYOSINHEAVY. DR SMART; SM00242; MYSc; 1. DR SUPFAM; SSF90257; Myosin rod fragments; 5. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR PROSITE; PS50096; IQ; 1. DR PROSITE; PS51456; MYOSIN_MOTOR; 1. DR PROSITE; PS51844; SH3_LIKE; 1. DR UCD-2DPAGE; Q9Y623; -. DR Genevisible; Q9Y623; HS. PE 2: Evidence at transcript level; KW Actin-binding; ATP-binding; Calmodulin-binding; Coiled coil; Cytoplasm; KW Methylation; Motor protein; Muscle protein; Myosin; Nucleotide-binding; KW Phosphoprotein; Reference proteome; Thick filament. FT CHAIN 1..1939 FT /note="Myosin-4" FT /id="PRO_0000123398" FT DOMAIN 33..82 FT /note="Myosin N-terminal SH3-like" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01190" FT DOMAIN 86..782 FT /note="Myosin motor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00782" FT DOMAIN 785..814 FT /note="IQ" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00116" FT REGION 659..681 FT /note="Actin-binding" FT /evidence="ECO:0000250" FT REGION 761..775 FT /note="Actin-binding" FT /evidence="ECO:0000250" FT COILED 843..1939 FT /evidence="ECO:0000255" FT BINDING 179..186 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255" FT MOD_RES 64 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 69 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 79 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 130 FT /note="N6,N6,N6-trimethyllysine" FT /evidence="ECO:0000255" FT MOD_RES 389 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 391 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 392 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 419 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 424 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 625 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 757 FT /note="Pros-methylhistidine" FT /evidence="ECO:0000250|UniProtKB:Q28641" FT MOD_RES 776 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1092 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1162 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1237 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1241 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1243 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1255 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1261 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1265 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1278 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1286 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1288 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1292 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1303 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1306 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1413 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1464 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1467 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1474 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1492 FT /note="Phosphotyrosine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1495 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1501 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1514 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1517 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1542 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1547 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1554 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1574 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1600 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1603 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1714 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1726 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1730 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1736 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT MOD_RES 1739 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q29RW1" FT VARIANT 594 FT /note="A -> T (in dbSNP:rs12949680)" FT /id="VAR_030198" FT VARIANT 883 FT /note="T -> M (in dbSNP:rs3744558)" FT /id="VAR_022110" FT VARIANT 1106 FT /note="I -> M (in dbSNP:rs917361)" FT /evidence="ECO:0000269|PubMed:10388558" FT /id="VAR_030199" FT VARIANT 1117 FT /note="A -> D (in dbSNP:rs16943441)" FT /id="VAR_030200" FT VARIANT 1209 FT /note="E -> K (in dbSNP:rs11651295)" FT /evidence="ECO:0000269|PubMed:10388558" FT /id="VAR_030201" FT VARIANT 1802 FT /note="D -> G (in dbSNP:rs2277649)" FT /evidence="ECO:0000269|PubMed:10388558" FT /id="VAR_030202" FT VARIANT 1862 FT /note="R -> C (in dbSNP:rs34260986)" FT /id="VAR_056175" FT VARIANT 1911 FT /note="K -> E (in dbSNP:rs3744554)" FT /evidence="ECO:0000269|PubMed:10388558" FT /id="VAR_024542" FT CONFLICT 1167 FT /note="M -> L (in Ref. 1; AAD29949)" FT /evidence="ECO:0000305" SQ SEQUENCE 1939 AA; 223071 MW; 023D6F73C476B19B CRC64; MSSDSEMAIF GEAAPFLRKS EKERIEAQNK PFDAKTSVFV VDPKESYVKA IVQSREGGKV TAKTEAGATV TVKEDQVFSM NPPKYDKIED MAMMTHLHEP AVLYNLKERY AAWMIYTYSG LFCVTVNPYK WLPVYNPEVV TAYRGKKRQE APPHIFSISD NAYQFMLTDR ENQSILITGE SGAGKTVNTK RVIQYFATIA VTGEKKKEEP ASGKMQGTLE DQIISANPLL EAFGNAKTVR NDNSSRFGKF IRIHFGATGK LASADIETYL LEKSRVTFQL KAERSYHIFY QILSNKKPEL IEMLLITTNP YDFAFVSQGE ITVPSIDDQE ELMATDSAVD ILGFTADEKV AIYKLTGAVM HYGNMKFKQK QREEQAEPDG TEVADKAAYL TSLNSADLLK SLCYPRVKVG NEFVTKGQTV QQVYNAVGAL AKAIYEKMFL WMVTRINQQL DTKQPRQYFI GVLDIAGFEI FDFNSLEQLC INFTNEKLQQ FFNHHMFVLE QEEYKKEGIE WEFIDFGMDL AACIELIEKP MGIFSILEEE CMFPKATDTS FKNKLYEQHL GKSNNFQKPK PAKGKPEAHF SLVHYAGTVD YNIAGWLDKN KDPLNETVVG LYQKSAMKTL AFLFSGAQTA EAEGGGGKKG GKKKGSSFQT VSALFRENLN KLMTNLRSTH PHFVRCIIPN ETKTPGAMEH ELVLHQLRCN GVLEGIRICR KGFPSRILYA DFKQRYKVLN ASAIPEGQFI DSKKASEKLL GSIEIDHTQY KFGHTKVFFK AGLLGTLEEM RDEKLAQLIT RTQAICRGFL MRVEFRKMME RRESIFCIQY NIRAFMNVKH WPWMKLYFKI KPLLKSAETE KEMANMKEEF EKTKEELAKT EAKRKELEEK MVTLMQEKND LQLQVQAEAD ALADAEERCD QLIKTKIQLE AKIKEVTERA EDEEEINAEL TAKKRKLEDE CSELKKDIDD LELTLAKVEK EKHATENKVK NLTEEMAGLD ETIAKLTKEK KALQEAHQQT LDDLQMEEDK VNTLTKAKTK LEQQVDDLEG SLEQEKKLCM DLERAKRKLE GDLKLAQEST MDTENDKQQL NEKLKKKEFE MSNLQGKIED EQALAIQLQK KIKELQARIE ELEEEIEAER ASRAKAEKQR SDLSRELEEI SERLEEAGGA TSAQIEMNKK REAEFQKMRR DLEESTLQHE ATAAALRKKH ADSVAELGEQ IDSLQRVKQK LEKEKSELKM EINDLASNME TVSKAKANFE KMCRTLEDQL SEIKTKEEEQ QRLINELSAQ KARLHTESGE FSRQLDEKDA MVSQLSRGKQ AFTQQIEELK RQLEEETKAK STLAHALQSA RHDCDLLREQ YEEEQEAKAE LQRGMSKANS EVAQWRTKYE TDAIQRTEEL EEAKKKLAQR LQDAEEHVEA VNSKCASLEK TKQRLQNEVE DLMIDVERSN AACIALDKKQ RNFDKVLAEW KQKYEETQAE LEASQKESRS LSTELFKVKN AYEESLDHLE TLKRENKNLQ QEISDLTEQI AEGGKHIHEL EKVKKQLDHE KSELQTSLEE AEASLEHEEG KILRIQLELN QVKSEIDRKI AEKDEELDQL KRNHLRVVES MQSTLDAEIR SRNDALRIKK KMEGDLNEME IQLNHANRQA AEALRNLRNT QGILKDTQLH LDDAIRGQDD LKEQLAMVER RANLMQAEVE ELRASLERTE RGRKMAEQEL LDASERVQLL HTQNTSLINT KKKLETDISQ IQGEMEDIVQ EARNAEEKAK KAITDAAMMA EELKKEQDTS AHLERMKKNM EQTVKDLQLR LDEAEQLALK GGKKQIQKLE ARVRELESEV ESEQKHNVEA VKGLRKHERR VKELTYQTEE DRKNILRLQD LVDKLQTKVK AYKRQAEEAE EQSNVNLAKF RKLQHELEEA KERADIAESQ VNKLRVKSRE VHTKVISEE //